Medical device to prevent hair loss in cancer patients

It is well known that oncologic patients receiving chemotherapy often loose their hair.

Particularly for women it is a very unpleasant effect which can even worsen the  patient’s psychical state or reduce its compliance. Research physicians at UCLA's Jonsson Comprehensive Cancer Center in the USA have begun a clinical trial on a new device that promises to reduce hair loss of patients receiving chemotherapy for breast cancer. The device is called DigniCap and its mechanism is based on cooling the patient's scalp (hair follicles) and so contracting the blood vessels around the roots of the hair. Thanks to that contraction less of the drug can reach them and harm them. Clinical trials have already been performed in and Asia.

Original source.


Register for receiving PharmaAround news, register for PharmAround events.
Continue registration